Abstract Details

Title Prevalence of and Annual Conversion Rates to Mild Cognitive Impairment and Dementia: Prospective, Longitudinal Study of an Essential Tremor Cohort

Topic Movement Disorders

Presentation(s) S35 - Movement Disorders: Hyperkinetic Movement Disorders (3:54 PM-4:06 PM)

Poster/Presentation
Number 003

Background Despite recent attention to cognitive impairment in ET, few studies examine rates of conversion to diagnoses of MCI and dementia. Development of dementia in ET is associated with loss of functional ability and a doubling of mortality rate. Furthermore, although a few studies have estimated one or two of the following six metrics in an ET cohort - cumulative prevalence of MCI and dementia, cumulative incidence of MCI and dementia, and annual conversion rate from normal cognition to MCI or dementia - none has comprehensively assessed all of these metrics within a single prospectively followed cohort.

Objective This prospective, longitudinal study comprehensively reports the prevalence and incidence of, and the annual rates of conversion to, mild cognitive impairment (MCI) and dementia in an essential tremor (ET) cohort.

Design/Methods

ET cases underwent detailed cognitive assessments and were assigned diagnoses of normal cognition (NC), MCI, or dementia. There were 222 cases at baseline (mean age = 79.3 + 9.7 years), and 177 cases participated in follow-up evaluations at 18, 36, 54, and 72 months (mean years of observation = 5.1 + 1.7). Data were compared to those of historical controls and Parkinson’s disease (PD) patients.

Results

The cumulative prevalence of dementia and average annual conversion rate of MCI to dementia were 18.5% and 12.2%, nearly three times higher than rates in the general population, and approximately one-half the magnitude of those reported for PD patients. The cumulative prevalence of MCI (26.6%) was almost double that of the general population, but less than that in PD populations.

Conclusions

We present the most complete exposition of the longitudinal trajectory of cognitive impairment in an ET cohort. Our data indicate that the prevalence of and conversion rates to dementia in ET fall between those associated with the natural course of aging and the more pronounced rates observed in individuals with PD.

Authors/Disclosures
Elan D. Louis, MD, MS, FAAN (University of Texas Southwestern Medical Center) PRESENTER	Dr. Louis has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wolters Kluwer - Merritt's Textbook of Neurology. Dr. Louis has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Legal Firm. The institution of Dr. Louis has received research support from National Institutes of Health. Dr. Louis has received publishing royalties from a publication relating to health care.
Ali Ghanem (UT Southwestern Medical Center)	No disclosure on file
Diane Berry (University of Texas Southwestern Medical Center)	No disclosure on file
Nora Hernandez	No disclosure on file
Vibhash D. Sharma, MD (University of Texas Southwestern Medical Center)	Dr. Sharma has nothing to disclose.
Silvia Chapman (CUMC)	No disclosure on file
Edward Huey	No disclosure on file
Stephanie Cosentino, PhD (Columbia University Medical Center)	Dr. Cosentino has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Association for Frontotemporal Dementia. Dr. Cosentino has received personal compensation in the range of $500-$4,999 for serving as a Consultant for SAGE Pharmaceuticals.